• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Dr. Carladenise Armbrister Edwards Joins Clover Health Board of Directors

    7/26/22 4:05:00 PM ET
    $CLOV
    Medical Specialities
    Health Care
    Get the next $CLOV alert in real time by email

    FRANKLIN, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Carladenise Armbrister Edwards, Ph.D., to the Company's Board of Directors.

    Dr. Edwards is an accomplished healthcare executive with nearly three decades of healthcare, nonprofit and government experience. Currently the Henry Ford Health System's Executive Vice President and Chief Strategy Officer, she leads the system's strategic planning efforts and partnership ventures, business development and transformation initiatives, government affairs strategy, as well as Henry Ford Innovations, the health system's multi-disciplinary team responsible for product design and commercialization, technology transfer, licensing agreements and international programs.

    "From strategic roles in government and public service, to executive leadership positions at some of the nation's leading academic medical centers, Dr. Edwards brings unmatched experience and depth of knowledge to Clover," said Vivek Garipalli, Chief Executive Officer of Clover. "Her track record of delivering results for multibillion dollar health and technology organizations and guiding them to optimal performance will be invaluable as we continue to strive to make data-driven primary care more equitable and accessible."

    "The Clover Health team is focused on solving some of healthcare's biggest problems," said Dr. Edwards. "I see Clover Assistant as a lever for alleviating some of the industry's toughest challenges, especially to the benefit of our most vulnerable populations, and look forward to working closely with the executive team over the coming months and years to manifest its fullest potential."

    Prior to Henry Ford, Dr. Edwards was Executive Vice President and Chief Strategy Officer for Providence St. Joseph Health, a $24 billion Catholic health system comprising 51 hospitals and more than 800 clinics across seven states. Dr. Edwards' experience includes several additional executive leadership roles, including Chief Administrative Officer for Providence Health & Services' Population Health division and Chief Strategy Officer for Alameda Health System.

    An expert in the intersection of healthcare and technology, Dr. Edwards also served as Founding President and CEO of Cal eConnect, Inc., a nonprofit corporation that governed California's electronic Health Information Exchange. She additionally held technology based leadership roles in Georgia's Department of Community Health.

    Dr. Edwards earned a Ph.D. in Medical Sociology from the University of Florida, and a master's degree in Education and Psychological Services and a bachelor's degree in Sociology from the University of Pennsylvania. Dr. Edwards also studied neuroscience at the University of Leuven in Belgium and gerontology at the University of California, Los Angeles.

    About Clover Health:

    Clover Health (NASDAQ:CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states. Our Non-Insurance line of business offers a variety of programs aimed at reducing expenditures and enhancing the quality of care for patients enrolled in fee-for-service Medicare. Clover's corporate headquarters are in Franklin, Tenn.

    Visit: www.cloverhealth.com

    Press Contact:

    Andrew Still-Baxter

    [email protected]

    Investor Relations Contact:

    Ryan Schmidt

    [email protected]



    Primary Logo

    Get the next $CLOV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLOV

    DatePrice TargetRatingAnalyst
    12/17/2024$6.00Buy
    Craig Hallum
    10/7/2024$4.00Neutral
    UBS
    2/25/2022$3.00 → $2.50Market Perform
    SVB Leerink
    2/2/2022$7.00 → $3.00Underperform → Market Perform
    Cowen & Co.
    2/2/2022$6.00Buy
    Canaccord Genuity
    1/19/2022$3.00Market Perform
    SVB Leerink
    1/10/2022$9.00 → $3.50Neutral
    Citigroup
    1/7/2022$9.00 → $3.50Neutral → Underperform
    Credit Suisse
    More analyst ratings

    $CLOV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO, Medicare Advantage Reynoso Jamie L. sold $58,487 worth of shares (20,450 units at $2.86), decreasing direct ownership by 0.64% to 3,196,401 units (SEC Form 4)

      4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

      6/18/25 5:26:15 PM ET
      $CLOV
      Medical Specialities
      Health Care
    • General Counsel & Secretary Soares Karen covered exercise/tax liability with 6,404 shares, decreasing direct ownership by 0.51% to 1,256,032 units (SEC Form 4)

      4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

      6/17/25 5:29:37 PM ET
      $CLOV
      Medical Specialities
      Health Care
    • CEO, Counterpart Health Wai Conrad covered exercise/tax liability with 98,411 shares, decreasing direct ownership by 3% to 3,138,535 units (SEC Form 4)

      4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

      6/17/25 5:26:06 PM ET
      $CLOV
      Medical Specialities
      Health Care

    $CLOV
    SEC Filings

    See more
    • SEC Form 144 filed by Clover Health Investments Corp.

      144 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)

      6/17/25 4:21:44 PM ET
      $CLOV
      Medical Specialities
      Health Care
    • Clover Health Investments Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

      6/12/25 4:27:22 PM ET
      $CLOV
      Medical Specialities
      Health Care
    • Clover Health Investments Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

      5/14/25 8:59:21 AM ET
      $CLOV
      Medical Specialities
      Health Care

    $CLOV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance

      First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover's technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjusted Net income of $25 million, up 322% year-over-year Improved Full Year 2025 Guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year

      5/6/25 4:05:00 PM ET
      $CLOV
      Medical Specialities
      Health Care
    • Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare

      USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 6, 2025 /PRNewswire/ -- Healthcare is quickly evolving into a digital-first operation, where top executives in the sector are doubling down on artificial intelligence, automation and analytics to reduce costs and improve billing accuracy. This is according to results of a survey from Everest Group (and supported by Omega Healthcare), which showed 85% of senior healthcare executives believe AI will improve efficiencies over the next five years. Now that multitasking AI Agents are being referred to as hospitals' newest "employees", AI-powered electronic noses are detecting scents for health and enviro

      5/6/25 9:45:00 AM ET
      $AMZN
      $CLOV
      $TDOC
      Catalog/Specialty Distribution
      Consumer Discretionary
      Medical Specialities
      Health Care
    • Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

      WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") and a leading AI-powered physician-enablement platform, today released research demonstrating how Counterpart Assistant ("CA") use is associated with better management of congestive heart failure ("CHF"). The analysis, titled "Driving Clinical Excellence in Chronic Disease: Counterpart Assistant's Role in Heart Failure Care," details the significant positive association among CHF patients between better clinical care and lower hospitalizations, and having a relationship with a PC

      5/1/25 4:30:00 PM ET
      $CLOV
      Medical Specialities
      Health Care